Laxmi Dental Share Price

Laxmi Dental Limited is a fully integrated dental products provider, offering a diverse range of solutions. The company has an end-to-end integrated business spanning custom-made crowns and bridges, branded dental products including clear aligners, thermoforming sheets, and aligner-related accessories, along with pediatric dental products. The Laxmi Dental share price on the NSE and BSE is a reflection of how market participants respond to a company’s performance and broader business developments within its industry. It captures the sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries.

Market sentiment around the Laxmi Dental stock price often mirrors shifts in healthcare spending, dental tourism trends, and investor views on the medical devices sector’s growth prospects. Factors such as the pace of product innovation, competitive intensity from domestic and international players, raw material costs, and government policies on healthcare influence near-term market valuation and medium-term earnings forecasts. All these factors must be closely monitored to have an idea about the Laxmi Dental stock price movements.

Laxmi Dental live share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant monitoring of Laxmi Dental live price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.

Furthermore, monitoring the Laxmi Dental share price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.

Laxmi Dental Limited Company Fundamentals

a. Company Background

Laxmi Dental Limited was incorporated in 2004. The company’s registered office is located in Mumbai, India. The company was originally incorporated as Laxmi Dental Export Private Limited on July 8, 2004. In June 2024, the Company name was changed to Laxmi Dental Private Limited, and a fresh Certificate of Incorporation was issued by the RoC on July 24, 2024. Thereafter, it converted into a Public Company as Laxmi Dental Limited, vide certified dated August 02, 2024, issued by the RoC. Laxmi Dental’s primary activity involves the manufacturing and sale of dental products, operating through three segments: Laboratory Business, Aligners Business, and Other Business. The company has six manufacturing facilities and a reach across 22,000 dental clinics, dental companies and dentists. Over the years, Laxmi Dental has significantly expanded its capabilities, launching clear aligners under the brand Illusion Aligners, the first Indian brand to receive 510(k) clearance from the US FDA in 2021. It also launched iScanPro intraoral scanners in March 2025. The company operates in a competitive environment, serving markets in India, the United States, the United Kingdom, and internationally.

b. Product Lines

• Custom-made crowns and bridges, including metal free restorations, porcelain fused to metal (PFM), and branded premium zirconia crowns (Illusion Zirconia)

• Clear aligners (Illusion Aligners), retainers, sport guards, night guards, and sleep apnea devices

• Thermoforming sheets, thermoforming machines, dental consumables, biocompatible resins for 3D printing under the brand Taglus

• Paediatric dental products including pre-formed branded pediatric crowns, silver diamide fluoride (SDF), space maintainers, fissure sealant, and mineral trioxide aggregate

• Intraoral scanners (iScanPro) for digital dentistry applications

• Dental distribution products for dental laboratories and clinical services

• Dental educational courses

c. Company Revenue Model

• Primary revenue from the sale of dental products across three segments: Laboratory Business (63% of revenues), Aligners Business (31% of revenues), and Other Business

• Volume-driven revenue based on the quantity of dental prosthesis, aligners, and consumables sold to dental clinics, laboratories, and dentists

• Revenue from exports to international markets, with the company earning 67% of its revenues from India, 19% from the United States, and 7% from the United Kingdom

• Revenue from brand licensing and sales of branded dental products including Illusion Zirconia and Illusion Aligners

• Revenue from digital dentistry solutions including intraoral scanners and 3D printing resins

• Processing fees and service charges from dental laboratory services and clinical services

• Seasonal variations in demand for dental products affecting revenue patterns throughout the year

• Government policy changes on healthcare spending and medical device regulations influencing revenue stability

d. Geographic Presence

• Strong presence across India with six manufacturing facilities

• Registered office and corporate headquarters located in Mumbai, Maharashtra

• Reach across 22,000 dental clinics, dental companies and dentists domestically and internationally

• International presence in the United States through foreign subsidiary Laxmi Dental Lab USA, Inc. (incorporated in 2012)

• Presence in the United Kingdom and other international markets

• Operations spanning three continents serving markets in Asia, North America, and Europe

e. Key Milestones

• 2004: Incorporated as Laxmi Dental Export Private Limited on July 8

• 2011: Moved to a bigger manufacturing facility at Kandivali Co-operative Industrial Estate Limited in Mumbai

• 2012: Incorporated foreign subsidiary, Laxmi Dental Lab USA, Inc

• 2019: Established Vedia Solutions Division for producing thermoforming sheets, 3D printing resins, and aligner accessories

• 2021: Launched Illusion Aligners, the first Indian brand to receive 510(k) clearance from US FDA

• 2021: Acquired 60% stake in Kids-E-Dental LLP for paediatric dental services and products

• 2024: Converted to a public limited company as Laxmi Dental Limited on August 2

• 2025: IPO opened from January 13 to January 15 at price band ₹407-428 per share

• 2025: Listed on NSE and BSE on January 20

• 2025: Launched iScanPro intraoral scanners in March

• 2025: Completed acquisition of Bizdent Devices Pvt Ltd on April 28

f. Industry Perspective

Laxmi Dental Limited operates in the dental consumables and equipment industry, which is a key segment of India’s broader healthcare and medical devices sector. Globally, the dental consumables market was valued at approximately USD 35 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6-7% from 2025 to 2030, driven by rising oral health awareness and cosmetic dentistry trends. In India, the dental consumables market is poised for rapid expansion. According to Grand View Research, the India dental consumables market generated a revenue of USD 1,226.4 million in 2023 and is expected to reach USD 2,582.4 million by 2030, growing at a CAGR of 11.2% from 2024 to 2030. The broader dental equipment and consumables market in India is expected to grow at a CAGR of 9.6% from 2025 to 2030, reaching USD 3,620.1 million by 2030. According to TechSci Research, the India Dental Consumables Market was valued at USD 234.65 million in 2024 and is expected to reach USD 377.79 million by 2030, rising at a CAGR of 8.22%. Dental implants remain the largest revenue-generating product segment, while endodontic materials are the fastest-growing segment. The government’s focus on healthcare access, the rise of dental tourism (with India attracting an estimated 7.3 million medical tourists in 2024), and the increasing adoption of digital dentistry are driving demand. Key challenges include reliance on imports for premium consumables, price sensitivity in rural markets, and intense competition from unorganized players.

Laxmi Dental Limited Stock Market Presence: Listings & Index Representation

Laxmi Dental is actively traded on India’s principal equity markets, with its shares listed on the National Stock Exchange of India (NSE) under the symbol LAXMIDENTL and on the Bombay Stock Exchange (BSE) with the scrip code 544339. The company’s ISIN number is INE0WO601020. Its listing on both exchanges ensures that the Laxmi Dental price is accessible to a wide investor base, encompassing both retail and institutional market participants. The company was listed on January 20, 2025, through an initial public offering (IPO) at an issue price of ₹428 per share, opening at a premium of 27% at ₹542 on listing day. The company forms part of several benchmark indices that represent broad market segments. Laxmi Dental is included in indices such as S&P BSE 500, S&P BSE AllCap, and S&P BSE SmallCap on the BSE. Being represented in multiple indices enhances the visibility and liquidity of the Laxmi Dental stock price, as index tracking funds and exchange traded strategies often adjust allocations in line with constituent revisions. It also allows investors to benchmark the company’s stock performance relative to broader market trends and peer groups, facilitating cross sectional comparisons within India’s dental products and healthcare landscape. The inclusion of Laxmi Dental in these indices reflects its market capitalisation and trading depth, which are key factors market participants consider when evaluating long term investment prospects and the responsiveness of the stock price to corporate and industry developments.

Laxmi Dental Limited Stock Performance and Share Price History

The Laxmi Dental price has exhibited significant volatility since its listing in January 2025, shaped by the company’s position as a niche dental products player and broader market conditions. The Laxmi Dental share price recorded a negative total return of approximately 59.63% from its issue price of ₹428 as of March 16, 2026, with the stock trading at ₹172.80, a 59.63% decline. The Laxmi Dental share price delivered a 1-year total return of -51.11% as of April 2026, underperforming the BSE Healthcare index which returned 2.5% during the same period. The Laxmi Dental share price reached a 52-week high of ₹509.95 on July 21, 2025, and a 52-week low of ₹155.88 on March 30, 2026, indicating a wide trading range and substantial price fluctuations of approximately ₹354 from peak to trough. The Laxmi Dental share price recorded a strong rally following its listing, with the stock opening at a 27% premium at ₹542 on January 20, 2025, while the subsequent period has seen the Laxmi Dental stock price correct significantly from its peak levels. The Laxmi Dental share price has shown a 1-month return of approximately 4% to 6.24% and a 3-month return of -31.4% as of April 2026, indicating recent consolidation.

The Laxmi Dental price has been particularly responsive to quarterly earnings releases and corporate announcements. When the company reported a 58.75% decline in net profit to ₹1.98 crore in the December 2025 quarter from ₹4.80 crore in the previous quarter, the Laxmi Dental stock price showed a negative reaction. The Laxmi Dental price has shown a pattern of positive momentum in the initial months following its listing when the company reported strong revenue growth, while periods of earnings moderation or concerns over valuation have contributed to consolidation in the Laxmi Dental stock price. Corporate developments, including strategic announcements such as the acquisition of Bizdent Devices Pvt Ltd, the launch of iScanPro intraoral scanners, and the expansion of the Illusion Aligners brand, have also influenced short-term fluctuations in the Laxmi Dental price. The Laxmi Dental share price has shown a 5-year return of None% due to its recent listing, and a 10-year return is not applicable as the company has been listed for just over one year. The Laxmi Dental share price reached its 52-week high of ₹509.95 before declining to its 52-week low of ₹155.88, reflecting the volatility inherent in the dental products space. The Laxmi Dental share price has shown a year-to-date return of approximately -32.5% as of April 2026, indicating continued pressure in the current fiscal year. Comprehending these patterns in the Laxmi Dental price is instrumental for investors seeking to contextualise long term performance trends vis à vis short term price dynamics, as the Laxmi Dental stock price movements illustrate how industry fundamentals, regulatory cycles, and investor expectations converge in market pricing.

The Laxmi Dental share price has shown distinct seasonal patterns since its listing. In terms of annual performance, the Laxmi Dental share price delivered positive returns in the initial weeks following its January 2025 listing, while the stock recorded negative returns throughout 2025 and into 2026. The Laxmi Dental share price has demonstrated that the stock tends to perform better in periods of strong dental consumables demand and positive investor sentiment toward healthcare IPOs, while underperforming during phases of broader market volatility and valuation concerns.

Laxmi Dental Limited Investor Relevance and Role in Portfolio

Laxmi Dental holds a significant position for portfolio investors who seek exposure to India’s dental products and healthcare sector with a focus on niche manufacturing. The company’s end-to-end integrated business model across crowns, bridges, aligners, and digital dentistry aligns it with investment strategies that value manufacturing scale, product innovation, and export growth. The Laxmi Dental share price often mirrors how these themes resonate with investor portfolios, whereby both thematic and sector specific funds monitor dental tourism trends, regulatory approval metrics, and export growth indicators when evaluating allocation decisions.

Institutional stakeholders play a significant role in Laxmi Dental’s ownership profile, with notable long term investment entities such as ICICI Prudential Pharma Healthcare and Diagnostics Fund (4.58%), HDFC Pharma and Healthcare Fund (1.37%), and Kotak Healthcare Fund (1.37%) among key mutual fund shareholders identified in institutional holdings data. Mutual fund holders of Laxmi Dental encompass those that seek healthcare and pharmaceutical exposure, including ICICI Prudential Mutual Fund, HDFC Mutual Fund, and Kotak Mahindra Mutual Fund. As of December 2025, promoters held 41.70% stake, Mutual Funds held 10.71%, Foreign Institutional Investors (FIIs) held 32.45%, Domestic Institutional Investors (DIIs) held 0.11%, and Retail held 15.02% of Laxmi Dental. FII/FPI holdings decreased from 34.24% in March 2025 to 32.45% in December 2025, while mutual funds decreased holdings from 13.89% to 10.71% over the same period. These investors represent a blend of domestic and international perspectives that contribute to the stock’s market liquidity and visibility within broader investment frameworks.

The beta analysis of Laxmi Dental across multiple time periods highlights its changing volatility in relation to the overall market. Based on data, the long-term beta is not available as the stock has been listed for just over one year, with insufficient historical price data for reliable calculation. Based on data from TradingView, the beta coefficient is 5.11, indicating that the stock is significantly more volatile than the broader market over short-term analysis. In short-term daily analysis, beta values show high sensitivity to recent market fluctuations. Weekly data reveals that Laxmi Dental’s weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks. The stock’s price volatility is approximately 8-9% according to recent data. The average weekly movement of Laxmi Dental stock is approximately 8%, compared to the healthcare industry average of 4-5% and the market average of 5-6%, indicating higher volatility than both its industry and the broader market. The Laxmi Dental share price has shown periods of heightened responsiveness to sector-specific news and quarterly earnings releases. The Laxmi Dental stock price’s high beta reflects that the company’s relatively small market capitalization and niche product focus may amplify its sensitivity to market movements, though the dental products sector remains sensitive to healthcare spending cycles and regulatory changes.

Laxmi Dental Limited Sectoral Relevance and Peer Positioning

The sector relevance of Laxmi Dental is anchored in its role within the broader Indian dental products and medical devices industry, where it competes with other healthcare and consumables companies. As part of this industry, the company’s strategic positioning connects dental prosthesis, clear aligners, and digital dentistry solutions to dental clinics, laboratories, and end consumers. Competitors in the dental products and medical devices segment include companies such as Poly Medicure Limited, Tarsons Products Limited, Borosil Limited, Nureca Limited, and Lenskart Solutions Limited (in the broader healthcare consumables space). Firms with parallels in either product portfolio scale or healthcare focus are often referenced when evaluating relative performance and operational positioning within the sector.

In valuation terms, factors like the Laxmi Dental P/E ratio have shown variations over different periods. The current P/E ratio of Laxmi Dental stands at approximately 35.7 to 54.3 times, representing a premium to its peers’ median range of 36.7 times, with some sources indicating a P/E of 66x compared to the peer average of 36.7x, suggesting the stock is trading at a premium. The Laxmi Dental P/E ratio has shown fluctuations since its IPO, reflecting changing investor perceptions of the company’s earnings growth potential.

Similarly, the Laxmi Dental EPS narrative has shown variation according to how operational performance aligns with industry demand cycles and cost structures. Structural gains from capacity expansion, new product launches, and export growth supported directional improvement in earnings per share during favourable conditions, while cyclical headwinds from raw material inflation and competitive pressures have moderated EPS momentum. Laxmi Dental earnings have shown a trajectory that responded to both revenue growth and margin pressures over the analysed period. Laxmi Dental market cap has fluctuated in line with investor perceptions of the company’s growth potential in a competitive and evolving dental products market, currently standing at approximately ₹957 crore to ₹1,016 crore.

Over the last year since its IPO in January 2025, the market capitalisation of Laxmi Dental has followed a pattern of significant decline from listing levels. The company’s market cap stood at approximately ₹2,966.31 crore on listing day (January 20, 2025), reflecting strong investor interest. Subsequently, from January 2025 through the most recent period, the market cap has shown a declining trend, contracting from its peak levels to approximately ₹901 crore to ₹1,016 crore as of April 2026. This represents a decline of approximately 65-70% from its listing peak. This decrease mirrors the correction in the Laxmi Dental share price and the broader underperformance of recent IPOs relative to broader market indices.

The earnings history of Laxmi Dental over the past five years (FY2021 to FY2025) has been characterised by a period of recovery from losses followed by recent moderation. Net income showed a generally improving trend, with reported net profit rising from a loss of ₹4.75 crore in FY2021 to a loss of ₹17.08 crore in FY2022, a loss of ₹4.45 crore in FY2023, turning positive to ₹17.94 crore in FY2024, and reaching ₹25.38 crore in FY2025. For the trailing twelve months, net profit stands at approximately ₹23 crore to ₹26 crore. Quarterly performance showed a 58.75% decline in net profit to ₹1.98 crore in the December 2025 quarter compared to ₹4.80 crore in the previous quarter. Revenue increased from ₹96.64 crore in FY2021 to ₹175.86 crore in FY2025, representing a total growth of 82% over five years. This recent earnings moderation reflects the impact of competitive pressures, raw material cost inflation, and demand normalization on the company’s profitability.

The Earnings Per Share (EPS) history for Laxmi Dental has shown variation over the past five years. The diluted EPS growth rate has shown variation, with EPS at ₹3.5 to ₹3.61 TTM, ₹4.41 as of recent data, and ₹2.5 according to other sources. Over a five-year period, the company demonstrated a turnaround from negative EPS to positive profitability. In recent years, EPS showed a pattern of improvement from negative territory in FY2022 and FY2023 to positive EPS in FY2024 and FY2025. The highest EPS growth was recorded in FY2024 when the company turned profitable, while recent quarters have shown moderation in per-share earnings.

The Price-to-Earnings (P/E) ratio history of Laxmi Dental has shown significant fluctuations since its IPO. At the end of recent periods, the P/E ratio varied, with the ratio at 35.7 as of April 11, 2026, 43.9 as of April 6, 2026, and 54.3 as of April 9, 2026. The mean historical P/E ratio over the short period since listing has been around 40-50 times. The current P/E ratio stands at a premium to the industry peer median of 36.7 times, reflecting that investor expectations remain anchored to the company’s growth potential despite near-term earnings headwinds. The Laxmi Dental share price has been influenced by these valuation metrics. The Laxmi Dental stock price continues to be evaluated in the context of its earnings potential and market position.

Summary

Laxmi Dental is a leading integrated dental products company in India listed on both the NSE and BSE, where the Laxmi Dental share price reflects healthcare spending cycles, dental tourism trends, and product innovation within the dental consumables sector. Its representation in multiple stock indices supports market visibility, while investor interest is shaped by earnings trends, valuation narratives, and broader healthcare access themes. Within the sector, the company’s competitive context and earnings dynamics provide key perspectives on its role in India’s dental products market.